Designing a decision aid for cancer prevention: a qualitative study
Family Practice · 2024
DOI: 10.1093/fampra/cmad042 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Family Practice, 2024. Verfasst von Shakira Milton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Research, University of Melbourne, Melbourne, Australia. Hauptthemen laut MEDLINE: Qualitative Research, Aspirin, Decision Support Techniques, Focus Groups. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Victorian Comprehensive Cancer Centre Precision Prevention Program, NHMRC, CanTest Collaborative.
Abstract (Originalsprache)
Objectives
Australian guidelines recommend people aged 50–70 years old consider taking low-dose aspirin to reduce their risk of colorectal cancer. The aim was to design sex-specific decision aids (DAs) with clinician and consumer input, including expected frequency trees (EFTs) to communicate the risks and benefits of taking aspirin.
Methods
Semi-structured interviews were conducted with clinicians. Focus groups were conducted with consumers. The interview schedules covered ease of comprehension, design, potential effects on decision-making, and approaches to implementation of the DAs. Thematic analysis was employed; independent coding by 2 researchers was inductive. Themes were developed through consensus between authors.
Results
Sixty-four clinicians were interviewed over 6 months in 2019. Twelve consumers aged 50–70 years participated in two focus groups in February and March 2020. The clinicians agreed that the EFTs would be helpful to facilitate a discussion with patients but suggested including an additional estimate of the effects of aspirin on all-cause mortality. The consumers felt favourable about the DAs and suggested changes to the design and wording to ease comprehension.
Conclusion
DAs were designed to communicate the risks and benefits of low-dose aspirin for disease prevention. The DAs are currently being trialled in general practice to determine their impact on informed decision-making and aspirin uptake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
- Department of General Practice, University of Melbourne, Melbourne, Australia.
- Department of Medicine, The University of Melbourne, Melbourne, Australia.
- Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
- Health and Government Sector, Quantium, Melbourne, Australia.
- School of Medicine, University of Western Sydney, Sydney, Australia.
ORCID-Profile: Shakira Milton, Finlay Macrae, Jennifer G McIntosh, Sibel Saya, Jon Emery
Förderung
- Victorian Comprehensive Cancer Centre Precision Prevention Program
- NHMRC
- CanTest Collaborative
- ARC Laureate Fellowship
- Cancer Research UK
Zitieren
APA
Milton, S., Macrae, F., McIntosh, J. G., Saya, S., Alphonse, P., Yogaparan, T., Karnchanachari, N., Novy, K., Nguyen, P., Lau, P., & Emery, J. (2024). Designing a decision aid for cancer prevention: a qualitative study. Family Practice. https://doi.org/10.1093/fampra/cmad042
Vancouver
Milton S, Macrae F, McIntosh JG, Saya S, Alphonse P, Yogaparan T, et al. Designing a decision aid for cancer prevention: a qualitative study. Family Practice. 2024. doi:10.1093/fampra/cmad042
BibTeX
@article{Milton2024,
author = {Milton, Shakira and Macrae, Finlay and McIntosh, Jennifer G and Saya, Sibel and Alphonse, Pavithran and Yogaparan, Thivagar and Karnchanachari, Napin and Novy, Kitty and Nguyen, Peter and Lau, Phyllis and Emery, Jon},
title = {Designing a decision aid for cancer prevention: a qualitative study},
journal = {Family Practice},
year = {2024},
doi = {10.1093/fampra/cmad042}
}
EUVIMED